Header Logo

Connection

MICHELLE A FANALE to Carmustine

Back to Details
This is a "connection" page, showing publications MICHELLE A FANALE has written about Carmustine.
MICHELLE A FANALE
Connection Strength
0.037
Carmustine
  1. Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. Biol Blood Marrow Transplant. 2018 08; 24(8):1602-1609.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.